63 related articles for article (PubMed ID: 2414171)
1. Response of granulocyte-committed progenitors from patients with chronic myeloid leukemia to humoral regulators release by macrophages in agar diffusion chamber culture.
Hansz J; Sawiński K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):415-23. PubMed ID: 2414171
[TBL] [Abstract][Full Text] [Related]
2. Modulation of human granulopoiesis by macrophage-derived growth regulators.
Hansz J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):3-7. PubMed ID: 2472324
[TBL] [Abstract][Full Text] [Related]
3. Splenic monocyte-macrophage dependent suppression of autologous granulocyte-progenitors growth in Hodgkin's disease.
Hansz J; Sawiński K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(2):203-11. PubMed ID: 2440776
[TBL] [Abstract][Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
5. [Proliferative activity of granulocyte progenitors from the bone marrow of patients with chronic myeloid leukemia in 14-day culture in vivo].
Hansz J; Kozłowska-Skrzypczak M
Acta Haematol Pol; 1989; 20(1):29-35. PubMed ID: 2618564
[TBL] [Abstract][Full Text] [Related]
6. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the presence in sera from chronic myelogenous leukemia patients of an activity that enhances the number of normal bone marrow-derived granulocyte/monocyte committed stem cell colonies.
Rao SG; Kothari V; Nadkarni K; Ahuja H; Advani S
Nouv Rev Fr Hematol (1978); 1987; 29(4):231-6. PubMed ID: 3501108
[TBL] [Abstract][Full Text] [Related]
8. Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoic acid and indomethacin.
Nilsson B; Olofsson T; Olsson I
Exp Hematol; 1984 Feb; 12(2):91-9. PubMed ID: 6583069
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
10. Special Education.
Kozutsumi H
Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
[TBL] [Abstract][Full Text] [Related]
11. Abnormal regulation of granulopoiesis by bone marrow fibroblasts in leukemia.
Shimizu M; Nagao T; Arimori S
Tokai J Exp Clin Med; 1987 May; 12(2):67-72. PubMed ID: 3482486
[TBL] [Abstract][Full Text] [Related]
12. Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1.
Aglietta M; Piacibello W; Gavosto F
Cancer Res; 1980 Jul; 40(7):2507-11. PubMed ID: 6930323
[TBL] [Abstract][Full Text] [Related]
13. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
Kubota K; Preisler HD; Costanzo C; Miura Y
Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
[TBL] [Abstract][Full Text] [Related]
14. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
16. Effects of S-phase-specific agents on granulocyte-macrophage and erythroid progenitor cells obtained from normal individuals and from patients with chronic myelogenous leukemia.
Kubota K; Preisler HD; Costanzo C
Cancer Res; 1983 Aug; 43(8):3927-31. PubMed ID: 6574819
[TBL] [Abstract][Full Text] [Related]
17. Lack of normal CFU-C/suppressor activity in population of alloantigen-stimulated T cells from patients with chronic myelogenous leukemia.
Maekawa T; Sonoda Y; Yokota S; Abe T
Exp Hematol; 1986 May; 14(4):316-23. PubMed ID: 2938981
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
19. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
[TBL] [Abstract][Full Text] [Related]
20. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
